GENE REWRITER
Live / Applied — First extension granted (statement of use) (as of 03 Dec 2025)
What this means for you
Not registered yet, but its 06 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98737788
- Mark type
- Stylized text
- Filed
- 06 Sept 2024
- Published for opposition
- 08 Apr 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 001 — Chemicals: Chemical and biological agents for scientific and research use, namely, for manipulating or modifying DNA
- Class 005 — Pharmaceuticals: Reagents for medical use, namely, molecular and cellular biology reagents and assays for the modification of cells and DNA; pharmaceutical preparations and therapeutic agents, namely, for gene therapy and DNA editing; pharmaceutical and biological preparations for medical use for the treatment of genetic and genomic disorders by gene, genome, and cellular editing, modulation, and modification for use in human and animal therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals
- Class 042 — Scientific and technological services: Research and development in the field of technology and engineering for the modification of DNA; development of new technology for others for enabling the engineering and modification of DNA, namely, developing molecular and cellular biology reagents, techniques, and assays for the modification of cells and DNA
Owner
- Tessera Therapeutics, Inc., Somerville, MA, US
- Tessera Therapeutics, Inc., Somerville, MA, US
Prosecution history
- 04 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Dec 2025 — SOU EXTENSION 1 GRANTED
- 03 Dec 2025 — SOU EXTENSION 1 FILED
- 03 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Apr 2025 — PUBLISHED FOR OPPOSITION
- 02 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Mar 2025 — ASSIGNED TO EXAMINER
- 17 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Sept 2024 — NEW APPLICATION ENTERED